Bariatric Surgery in Patients with Cirrhosis

  • Zubaidah Nor Hanipah
  • Linden Karas
  • Philip R. Schauer


Obesity, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) have been increasing globally leading to higher incidences of liver cirrhosis. Bariatric/Metabolic surgery is an effective long-term treatment of obesity, type 2 diabetes, and associated comorbidities providing significant cardiovascular risk reduction. Multiple studies have demonstrated significant histological improvement in NASH following metabolic surgery. Although patients with cirrhosis undergoing metabolic surgery have a higher perioperative risk than the general population, reported mortality and complication rates are less than expected compared to other major abdominal procedures. A multidisciplinary team approach is recommended for the management of bariatric surgery patients with cirrhosis in order to optimize outcomes.


Bariatric Surgery Metabolic Surgery Obesity Cirrhosis Diabetes Nonalcoholic steatohepatitis 


  1. 1.
    Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40:S5–10.PubMedGoogle Scholar
  2. 2.
    Stephen S, Baranova A, Younossi ZM. Nonalcoholic fatty liver disease and bariatric surgery. Expert Rev Gastroenterol Hepatol. 2012;6(2):163–71.CrossRefPubMedGoogle Scholar
  3. 3.
    Sanyal AJ. NASH: a global health problem. Hepatol Res. 2011;41(7):670–4.CrossRefPubMedGoogle Scholar
  4. 4.
    Koehler E, Watt K, Charlton M. Fatty liver and liver transplantation. Clin Liver Dis. 2009;13(4):621–30.CrossRefPubMedGoogle Scholar
  5. 5.
    Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;191(2):235–40.CrossRefPubMedGoogle Scholar
  6. 6.
    Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis of observational studies. J Hepatol. 2016;65:589–600.CrossRefPubMedGoogle Scholar
  7. 7.
    Adams LA, Lymp JF, Sauver JS, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113–21.CrossRefPubMedGoogle Scholar
  8. 8.
    Jepsen P, Vilstrup H, Mellemkjaer L, Thulstrup AM, Olsen JH, Baron JA, Sørensen HT. Prognosis of patients with a diagnosis of fatty liver–a registry-based cohort study. Hepato-Gastroenterology. 2002;50(54):2101–4.Google Scholar
  9. 9.
    Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44(4):865–73.CrossRefPubMedGoogle Scholar
  10. 10.
    Brethauer SA, Chand B, Schauer PR. Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med. 2006;73(11):993.CrossRefPubMedGoogle Scholar
  11. 11.
    Ponce J, DeMaria EJ, Nguyen NT, Hutter M, Sudan R, Morton JM. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surg Obes Relat Dis. 2016;12:1637–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Scopinaro N. Thirty-five years of biliopancreatic diversion: notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation. Obes Surg. 2012;22(3):427–32.CrossRefPubMedGoogle Scholar
  13. 13.
    Sethi M, Chau E, Youn A, Jiang Y, Fielding G, Ren-Fielding C. Long-term outcomes after biliopancreatic diversion with and without duodenal switch: 2-, 5-, and 10-year data. Surg Obes Relat Dis. 2016;12:1697–705.CrossRefPubMedGoogle Scholar
  14. 14.
    Brolin RE, Bradley LJ, Taliwal RV. Unsuspected cirrhosis discovered during elective obesity operations. Arch Surg. 1998;133(1):84–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Shimizu H, Phuong V, Maia M, Kroh M, Chand B, Schauer PR, Brethauer SA. Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis. 2013;9(1):1–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Jan A, Narwaria M, Mahawar KK. A systematic review of bariatric surgery in patients with liver cirrhosis. Obes Surg. 2015;25(8):1518–26.CrossRefPubMedGoogle Scholar
  17. 17.
    Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, Ahlin S, Anveden Å, Bengtsson C, Bergmark G, Bouchard C. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.CrossRefPubMedGoogle Scholar
  18. 18.
    Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.CrossRefPubMedGoogle Scholar
  19. 19.
    Dallal RM, Mattar SG, Lord JL, Watson AR, Cottam DR, Eid GM, Hamad G, Rabinovitz M, Schauer PR. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg. 2004;14(1):47–53.CrossRefPubMedGoogle Scholar
  20. 20.
    Rabl C, Campos GM. The impact of bariatric surgery on nonalcoholic steatohepatitis. Sem Liver Dis. 2012;32(01):80–91. Thieme Medical PublishersCrossRefGoogle Scholar
  21. 21.
    Mattar SG, Velcu LM, Rabinovitz M, Demetris AJ, Krasinskas AM, Barinas-Mitchell E, Eid GM, Ramanathan R, Taylor DS, Schauer PR. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg. 2005;242(4):610–20.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Kral JG, Thung SN, Biron S, Hould FS, Lebel S, Marceau S, Simard S, Marceau P. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery. 2004;135(1):48–58.CrossRefPubMedGoogle Scholar
  23. 23.
    Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98:1763–77.CrossRefPubMedGoogle Scholar
  24. 24.
    Schauer PR, Bhatt DL, Kirwan JP, et al.; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes–3-year outcomes. N Engl J Med. 2014;370:2002–13.Google Scholar
  25. 25.
    Bolen SD, Chang HY, Weiner JP, Richards TM, Shore AD, Goodwin SM, Johns RA, Magnuson TH, Clark JM. Clinical outcomes after bariatric surgery: a five-year matched cohort analysis in seven US states. Obes Surg. 2012;22(5):749–63.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237(6):751–8.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Neeff H, Mariaskin D, Spangenberg HC, Hopt UT, Makowiec F. Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores. J Gastrointest Surg. 2011;15(1):1–1.CrossRefPubMedGoogle Scholar
  28. 28.
    Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9(10):897–901.CrossRefPubMedGoogle Scholar
  29. 29.
    Aminian A, Andalib A, Khorgami Z, Cetin D, Burguera B, Bartholomew J, Brethauer SA, Schauer PR. Who should get extended thromboprophylaxis after bariatric surgery?: A risk assessment tool to guide indications for post-discharge pharmacoprophylaxis. Ann Surg. 2017;265(1):143–150.Google Scholar
  30. 30.
    The American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis. 2013;9(4):493–7.CrossRefGoogle Scholar
  31. 31.
    Consensus Development Conference Panel. NIH conference. Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115:956–61.CrossRefGoogle Scholar
  32. 32.
    Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39(6):861–77.CrossRefPubMedGoogle Scholar
  33. 33.
    Kim JJ, Dasika NL, Yu E, Fontana RJ. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery. J Clin Gastroenterol. 2009;43(6):574–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity. 2013;21(S1):S1–27.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Lopez-Delgado JC, Ballus J, Esteve F, Betancur-Zambrano NL, Corral-Velez V, Mañez R, Betbese AJ, Roncal JA, Javierre C. Outcomes of abdominal surgery in patients with liver cirrhosis. World J Gastroenterol. 2016;22(9):2657.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Zubaidah Nor Hanipah
    • 1
  • Linden Karas
    • 1
  • Philip R. Schauer
    • 1
  1. 1.Bariatric and Metabolic Institute, M61Cleveland ClinicClevelandUSA

Personalised recommendations